ArticleDiabetes, obesity & metabolism2026

Sodium glucose co-transporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors and the risk of ventricular arrhythmia among patients with type 2 diabetes: A population-based cohort study.

Wang-Choi Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.